Melbourne, Australia (23 March, 2012). Verva Pharmaceuticals Ltd. regretfully reports the recent passing of Verva Director Dr. Andrew Baker after a battle with cancer. Andrew was 50 years old. He is survived by his wife Nancy, son Sam and daughter Clare.
Andrew was a Partner at GBS Venture Partners and one of Verva’s founding Directors. Andrew drew on his extensive international industry experience (including work with industry leaders Genentech, Bayer and Johnson & Johnson) to provide essential guidance and strategic advice in advancing Verva’s corporate and product development programs.
Verva CEO Vince Wacher stated: “We are very saddened by Andrew’s untimely loss and express our heartfelt condolences to his family.”
A Memorial Service for Andrew will be held at St. Leonards Uniting Church, 2 Wolseley Ave, Brighton, Victoria on Monday 26 March 26, 2012 at 1.30 p.m. In lieu of flowers, donations to the Australasian Sarcoma Study Group would be greatly appreciated. http://www.australiansarcomagroup.org/support-sarcoma-research.html. Please note Andrew Baker as the bequest.
Andrew’s seat on the Verva board will be assumed by Dr. Steve Gourlay, also a Partner at GBS Venture Partners.